7.50
+0.03
+(0.43%)
At close: January 31 at 8:00:44 AM GMT+1
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 2.84M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| PISKEL KYLE Chief Financial Officer | Sale at price 4.98 per share. | Direct | 1,235 | Nov 18, 2024 |
| BOBULSKY SUSAN Officer | Conversion of Exercise of derivative security at price 1.98 per share. | Direct | 9,900 | Oct 8, 2024 |
| TAYLOR STACY L General Counsel | Sale at price 4.50 per share. | Direct | 121,079 | Aug 22, 2024 |
| PISKEL KYLE Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2024 |
| NEUPERT PETER M Director | Conversion of Exercise of derivative security at price 0.84 per share. | Direct | 12,600 | Mar 12, 2024 |
| LO FRANCIS Officer | Sale at price 3.43 - 3.44 per share. | Direct | 50,439 | Mar 5, 2024 |
| TAYLOR STACY L General Counsel | Sale at price 3.43 - 3.44 per share. | Direct | 45,963 | Mar 5, 2024 |
| BOBULSKY SUSAN Officer | Sale at price 3.43 - 3.44 per share. | Direct | 44,629 | Mar 5, 2024 |
| PETERSON TYCHO Chief Financial Officer | Sale at price 3.44 per share. | Direct | 53,169 | Mar 5, 2024 |
| RUBINSTEIN JULIAN President | Sale at price 3.43 - 3.56 per share. | Direct | 135,764 | Mar 5, 2024 |
| PISKEL KYLE Officer | Sale at price 3.43 per share. | Direct | 26,504 | Mar 5, 2024 |
| BENZENO SHARON Officer | Sale at price 3.43 - 3.44 per share. | Direct | 100,994 | Mar 5, 2024 |
| ROBINS CHAD M Chief Executive Officer | Sale at price 3.43 - 3.44 per share. | Direct | 167,007 | Mar 5, 2024 |
| GRIFFIN MICHELLE RENEE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| PELLINI MICHAEL J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| NEUPERT PETER M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| HERSHBERG ROBERT M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| PISKEL KYLE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| BENZENO SHARON Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| ROBINS CHAD M Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| RUBINSTEIN JULIAN President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| ROBINS HARLAN S. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| LO FRANCIS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| TAYLOR STACY L General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| BOBULSKY SUSAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| OWEN KATEY EINTERZ Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| PETERSON TYCHO Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| NEUPERT PETER M Director | Conversion of Exercise of derivative security at price 0.84 per share. | Direct | 84,000 | Dec 13, 2023 |
| PISKEL KYLE Officer | Sale at price 4.13 per share. | Direct | 1,070 | Nov 16, 2023 |
| SOOD NITIN Officer | Sale at price 6.54 - 6.78 per share. | Direct | 107,318 | Aug 8, 2023 |
| PETERSON TYCHO Chief Financial Officer | Conversion of Exercise of derivative security at price 7.30 per share. | Direct | 985,215 | Jun 20, 2023 |
| PETERSON TYCHO Chief Financial Officer | Sale at price 8.14 per share. | Direct | 1,098,583 | Jun 20, 2023 |
| PETERSON TYCHO Chief Financial Officer | Conversion of Exercise of derivative security at price 7.30 per share. | Direct | 104,594 | Jun 15, 2023 |
| PETERSON TYCHO Chief Financial Officer | Sale at price 8.53 per share. | Direct | 597,100 | Jun 15, 2023 |
| PETERSON TYCHO Chief Financial Officer | Sale at price 7.16 per share. | Direct | 272,080 | Jun 2, 2023 |
| ADAMS R MARK Chief Operating Officer | Sale at price 8.50 - 8.63 per share. | Direct | 26,863 | Apr 11, 2023 |
| GRIFFIN MICHELLE RENEE Director | Sale at price 8.49 per share. | Direct | 19,878 | Mar 27, 2023 |
| TAYLOR STACY L General Counsel | Sale at price 8.57 - 8.60 per share. | Direct | 162,186 | Mar 7, 2023 |
| ADAMS R MARK Chief Operating Officer | Sale at price 8.57 - 8.60 per share. | Direct | 203,487 | Mar 7, 2023 |
| SOOD NITIN Officer | Sale at price 8.57 - 8.60 per share. | Direct | 141,477 | Mar 7, 2023 |
| LO FRANCIS Officer | Sale at price 8.57 per share. | Direct | 58,413 | Mar 6, 2023 |
| RUBINSTEIN JULIAN President | Sale at price 8.57 per share. | Direct | 194,265 | Mar 6, 2023 |
| PISKEL KYLE Officer | Sale at price 8.57 - 8.58 per share. | Direct | 30,246 | Mar 6, 2023 |
| BENZENO SHARON Officer | Sale at price 8.57 per share. | Direct | 100,689 | Mar 6, 2023 |
| GRIFFIN MICHELLE RENEE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
| PELLINI MICHAEL J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
| NEUPERT PETER M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
| HERSHBERG ROBERT M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
| TRIGG LESLIE L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
| CONROY KEVIN T Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
Related Tickers
RGO.F Regeneron Pharmaceuticals, Inc.
655.40
-0.21%
REGN34.SA Regeneron Pharmaceuticals, Inc.
65.74
-1.81%
1MRNA.MI Moderna, Inc.
39.44
-2.13%
BEAM Beam Therapeutics Inc.
25.92
-4.99%
SANA Sana Biotechnology, Inc.
3.2200
-7.74%
DNA Ginkgo Bioworks Holdings, Inc.
13.36
-3.95%
DWTX Dogwood Therapeutics, Inc.
12.49
-2.12%
CRSP CRISPR Therapeutics AG
41.59
-1.07%
AKRO Akero Therapeutics, Inc.
54.08
-2.31%
MRNA Moderna, Inc.
39.42
-3.95%